ArticleThe oncologist2021

Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.

Dylan J Martini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.